Yu Junying, Hu Kejin, Smuga-Otto Kim, Tian Shulan, Stewart Ron, Slukvin Igor I, Thomson James A
Morgridge Institute for Research, Madison, WI 53707-7365, USA.
Science. 2009 May 8;324(5928):797-801. doi: 10.1126/science.1172482. Epub 2009 Mar 26.
Reprogramming differentiated human cells to induced pluripotent stem (iPS) cells has applications in basic biology, drug development, and transplantation. Human iPS cell derivation previously required vectors that integrate into the genome, which can create mutations and limit the utility of the cells in both research and clinical applications. We describe the derivation of human iPS cells with the use of nonintegrating episomal vectors. After removal of the episome, iPS cells completely free of vector and transgene sequences are derived that are similar to human embryonic stem (ES) cells in proliferative and developmental potential. These results demonstrate that reprogramming human somatic cells does not require genomic integration or the continued presence of exogenous reprogramming factors and removes one obstacle to the clinical application of human iPS cells.
将分化的人类细胞重编程为诱导多能干细胞(iPS细胞)在基础生物学、药物开发和移植领域都有应用。此前人类iPS细胞的诱导需要整合到基因组中的载体,这可能会产生突变,并限制这些细胞在研究和临床应用中的效用。我们描述了使用非整合型附加体载体诱导人类iPS细胞的方法。去除附加体后,可获得完全不含载体和转基因序列的iPS细胞,这些细胞在增殖和发育潜力方面与人类胚胎干细胞(ES细胞)相似。这些结果表明,重编程人类体细胞不需要基因组整合或持续存在外源性重编程因子,并且消除了人类iPS细胞临床应用的一个障碍。